How the U.S. Inflation Reduction Act Will Impact the Biopharmaceutical Industry
The U.S. Inflation Reduction Act is a step forward in improving affordability of innovative treatments for disease. Several key provisions found in the legislation will directly impact drug pricing. L.E.K. Consulting examines four key steps drug manufacturers can take to position themselves for growth as the legislation evolves and takes effect.
